Suppr超能文献

Nrf2 隔离 Keap1 防止 Podosome 解体:内皮细胞中不可或缺的二重奏。

Nrf2 Sequesters Keap1 Preventing Podosome Disassembly: A Quintessential Duet Moonlights in Endothelium.

机构信息

1 Department of Medical Biotechnology, Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University , Krakow, Poland .

2 Mass Spectrometry Laboratory, Institute of Biochemistry and Biophysics , Polish Academy of Science, Warsaw, Poland .

出版信息

Antioxid Redox Signal. 2019 May 10;30(14):1709-1730. doi: 10.1089/ars.2018.7505. Epub 2018 Oct 25.

Abstract

AIMS

Nrf2 (nuclear factor erythroid 2-like 2) is a transcription factor known to modulate blood vessel formation. Various experimental settings, however, attribute to Nrf2 either stimulatory or repressive influence on angiogenesis. Our findings unveil the mechanism of Nrf2-dependent vessel formation, which reaches beyond transactivation of gene expression and reconciles previous discrepancies.

RESULTS

We provide evidence that growth differentiation factor 15 (GDF-15)- and stromal cell-derived factor 1 (SDF-1)-induced angiogenesis strongly depends on the presence of Nrf2 protein but does not rely on its transcriptional activity. Instead, Nrf2 serves as a protein restraining Keap1 (Kelch-like ECH-associated protein 1), its known transcriptional repressor. Angiogenic response is abrogated in Nrf2-deficient endothelial cells but not in cells expressing dominant negative form or Keap1-binding fragment of Nrf2. Deficiency of Nrf2 protein available for Keap1 leads to the overabundance of RhoGAP1 (Rho GTPase-activating protein 1), the protein regulating cell division cycle 42 (Cdc42) activity. This impairs podosome assembly and disrupts actin rearrangements, thereby preventing angiogenesis. Effects of Nrf2 deficiency can be rescued by concomitant knockdown of RhoGAP1 or Keap1. Importantly, in the established murine model of Nrf2 deficiency, the N-terminal fragment of Nrf2 containing Keap1 binding domain is preserved. Thus, this model can be used to characterize Nrf2 as a transcription factor, but not as a Keap1-sequestering protein. Innovation and Conclusion: To date, the significance of Nrf2 in cell function has been ascribed solely to the regulation of transcription. We demonstrate that Nrf2 serves as a protein tethering Keap1 to allow podosome assembly and angiogenesis. Moreover, we emphasize that the new Nrf2 function of a Keap1 scavenger implies revisiting the interpretation of some of the previous data on the Nrf2-Keap1 system.

摘要

目的

Nrf2(核因子红细胞 2 样 2)是一种已知调节血管形成的转录因子。然而,各种实验条件将 Nrf2 对血管生成的影响归因于刺激或抑制。我们的发现揭示了 Nrf2 依赖性血管形成的机制,该机制超越了基因表达的反式激活,并调和了以前的差异。

结果

我们提供的证据表明,生长分化因子 15(GDF-15)和基质细胞衍生因子 1(SDF-1)诱导的血管生成强烈依赖于 Nrf2 蛋白的存在,但不依赖于其转录活性。相反,Nrf2 作为一种蛋白束缚 Keap1(Kelch-like ECH-associated protein 1),其已知的转录抑制剂。在 Nrf2 缺陷的内皮细胞中,血管生成反应被阻断,但在表达显性负形式或 Nrf2 的 Keap1 结合片段的细胞中则不然。用于 Keap1 的 Nrf2 蛋白的缺乏导致 RhoGAP1(Rho GTPase-activating protein 1)的过度表达,该蛋白调节细胞分裂周期 42(Cdc42)的活性。这会损害 Podosome 组装并破坏肌动蛋白重排,从而阻止血管生成。通过同时敲低 RhoGAP1 或 Keap1 可以挽救 Nrf2 缺陷的影响。重要的是,在已建立的 Nrf2 缺陷小鼠模型中,保留了含有 Keap1 结合结构域的 Nrf2 的 N 端片段。因此,该模型可用于将 Nrf2 作为转录因子进行表征,但不作为 Keap1 隔离蛋白。创新和结论:迄今为止,Nrf2 在细胞功能中的意义仅归因于转录的调节。我们证明 Nrf2 作为一种蛋白束缚 Keap1 以允许 Podosome 组装和血管生成。此外,我们强调,Nrf2 作为 Keap1 清除剂的新功能意味着需要重新解释以前关于 Nrf2-Keap1 系统的一些数据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验